Smith Jason Drew
CIK 0001821479
General Counsel
Filings
11
Latest Feb 11, 2026
Issuers covered
1
Showing
11 of 11
Page 1
Track record
19 of 19 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 19 | 63% | +1.9% | +1.9% | +21.7% | -15.8% |
| 90 days | 19 | 47% | -2.1% | -3.6% | +26.5% | -37.5% |
| 180 days | 16 | 38% | -26.6% | -2.7% | +25.7% | -108.5% |
| 365 days | 14 | 50% | -16.6% | -7.1% | +30.8% | -78.9% |
Issuers
Companies where Smith Jason Drew has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| URGN | Urogen Pharma Ltd. | 11 | Feb 11, 2026 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|